IGF1 and neoplasm: Along the same line, some tumor cytokines, including Interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6, were found to be elevated in HCC patients [27], have been reported to block IGF-1 production in the liver [28], [29].